Isolation and characterization of myofibroblast cell lines from oral squamous cell carcinoma

Oncology Reports

Volumn 25, Issue 4, 2011, Pages 1013-1020

  Sobral, Lays Martin ^a   Zecchin, Karina Gottardello ^a   De Aquino, Sibele Nascimento ^a   Lopes, Marcio Ajudarte ^a   Graner, Edgard ^a   Coletta, Ricardo D ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cell culture; Matrix metalloproteinase; Myofibroblast; Oral cancer; Proliferation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGENASE 3; CYTOKERATIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; PAN CYTOKERATIN; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CANCER INVASION; CELL CLONE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUTH CARCINOMA; MYOFIBROBLAST; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ACTINS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASES; MOUTH NEOPLASMS; MUSCLE, SMOOTH; MYOFIBROBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 79952215348     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1161     Document Type: Article

References (48)

1. Mueller MM and Fusenig NE: Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849, 2004. (Pubitemid 39472951)
2. Micke P and Ostman A: Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45 (Suppl. 2): S163-S175, 2004.
3. Micke P and Ostman A: Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert Opin Ther Targets 9: 1217-1233, 2005. (Pubitemid 41762875)
4. Albini A and Sporn MB: The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139-147, 2007.
5. Madani I, De Neve W and Mareel M: Does ionizing radiation stimulate cancer invasion and metastasis? Bull Cancer 95: 292-300, 2008.
6. Ziober AF, Falls EM and Ziober BL: The extracellular matrix in oral squamous cell carcinoma: friend or foe? Head Neck 28: 740-749, 2006.
7. Kim R, Emi M, Tanabe K and Arihiro K: Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res 66: 5527-5536, 2006. (Pubitemid 43927099)
8. Witz IP: Tumor-microenvironment interactions: the selectin-selectin ligand axis in tumor-endothelium cross talk. Cancer Treat Res 130: 125-140, 2006.
9. Desmouliere A, Guyot C and Gabbiani G: The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48: 509-517, 2004. (Pubitemid 39360401)
10. Desmouliere A, Chaponnier C and Gabbiani G: Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13: 7-12, 2005.
11. Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503, 2003.
12. Sobral LM, Montan PF, Martelli-Junior H, Graner E and Coletta RD: Opposite effects of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival cell cultures. J Clin Periodontol 34: 397-406, 2007.
13. Powell DW, Adegboyega PA, Di Mari JF and Mifflin RC: Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol 289: G2-G7, 2005. (Pubitemid 40944217)
14. Hinz B and Gabbiani G: Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb Haemost 90: 993-1002, 2003. (Pubitemid 38004416)
15. Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 92: 47-56, 2004. (Pubitemid 38147370)
16. De Wever O, Demetter P, Mareel M and Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238, 2008.
17. Jodele S, Blavier L, Yoon JM and DeClerck YA: Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25: 35-43, 2006. (Pubitemid 43723980)
18. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, Nishimoto I, Kowalski LP anf Coletta RD: Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 51: 849-853, 2007. (Pubitemid 350179411)
19. Kawashiri S, Tanaka A, Noguchi N, Hase T, Nakaya H, Ohara T, Kato K and Yamamoto E: Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck 31: 1346-1353, 2009.
20. Lewis MP, Lygoe KA, Nystrom ML, Anderson WP, Speight PM, Marshall JF and Thomas GJ: Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 90: 822-832, 2004. (Pubitemid 38406593)
21. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, Kowalski LP and Coletta RD: Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast trans- differentiation and modulation of tumor cell proliferation. Oral Oncol 44: 509-517, 2008. (Pubitemid 351608623)
22. Bitu CC, Sobral LM, Kellermann MG, Martelli-Junior H, Zecchin KG, Graner E and Coletta RD: Heterogeneous presence of myofibroblasts in hereditary gingival fibromatosis. J Clin Periodontol 33: 393-400, 2006. (Pubitemid 43742619)
23. Coletta RD, Almeida OP, Reynolds MA and Sauk JJ: Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-beta 1 autocrine stimulation. J Periodontal Res 34: 457-463, 1999.
24. Petrov VV, Fagard RH and Lijnen PJ: Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39: 258-263, 2002. (Pubitemid 34165225)
25. Liotta LA and Kohn EC: The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
26. Pietras K and Ostman A: Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316: 1324-1331, 2010.
27. Franco OE, Shaw AK, Strand DW and Hayward SW: Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21: 33-39, 2010.
28. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011, 1999. (Pubitemid 29472907)
29. Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004. (Pubitemid 39551661)
30. Casey TM, Eneman J, Crocker A, White J, Tessitore J, Stanley M, Harlow S, Bunn JY, Weaver D, Muss H and Plaut K: Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat 110: 39-49, 2008. (Pubitemid 351793849)
31. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD: Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926, 2008. (Pubitemid 351206771)
32. Liao D, Luo Y, Markowitz D, Xiang R and Reisfeld RA: Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS One 4: e7965, 2009.
33. Vered M, Dayan D, Dobriyan A, Yahalom R, Shalmon B, Barshack I, Bedrin L, Talmi YP and Taicher S: Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol 136: 1039-1048, 2010.
34. Dimanche-Boitrel MT, Vakaet L Jr, Pujuguet P, Chauffert B, Martin MS, Hammann A, Van Roy F, Mareel M and Martin F: In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer 56: 512-521, 1994.
35. Fregnani ER, Sobral LM, Alves FA, Soares FA, Kowalski LP and Coletta RD: Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical. Pathol Oncol Res 15: 231-240, 2009.
36. Eyden B: The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure, part 2 -tumours and tumour-like lesions. J Submicrosc Cytol Pathol 37: 231-296, 2005.
37. Liu Y, Hu T, Shen J, Li SF, Lin JW, Zheng XH, Gao QH and Zhou HM: Separation, cultivation and biological characteristics of oral carcinoma-associated fibroblasts. Oral Dis 12: 375-380, 2006. (Pubitemid 43926815)
38. Webber MM, Trakul N, Thraves PS, Bello-DeOcampo D, Chu WW, Storto PD, Huard TK, Rhim JS and Williams DE: A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis 20: 1185-1192, 1999. (Pubitemid 29341437)
39. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003. (Pubitemid 36542523)
40. Roy R, Yang J and Moses MA: Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297, 2009.
41. Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP and Graner E: Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol 20: 189-194, 2002.
42. McKaig BC, McWilliams D, Watson SA and Mahida YR: Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 162: 1355-1360, 2003. (Pubitemid 36350679)
43. Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schumacher P, Biesterfeld S, Galle PR, Lohse AW and Kanzler S: Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol 45: 419-428, 2006. (Pubitemid 44142114)
44. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P and Basset P: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92: 2730-2734, 1995.
45. Seomun Y, Kim J, Lee EH and Joo CK: Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells. Biochem J 358: 41-48, 2001. (Pubitemid 32778096)
46. Bisson C, Blacher S, Polette M, Blanc JF, Kebers F, Desreux J, Tetu B, Rosenbaum J, Foidart JM, Birembaut P and Noel A: Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer 105: 7-13, 2003. (Pubitemid 36418478)
47. Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10: 415-433, 2000.
48. Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR, Dano K and Lopez-Otin C: Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 61: 7091-7100, 2001. (Pubitemid 32946500)